Labshake search
Citations for Bio X Cell :
201 - 239 of 239 citations for Alpha Actinin 4 Rabbit Recombinant mAb since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2020Quote: ... The PBMCs were stimulated with 4 μg/mL plate-bound anti-CD3 antibody (clone OKT3; Bio X cell), 2 μg/mL soluble anti-CD28 antibody (clone CD28.2 ...
-
bioRxiv - Immunology 2021Quote: Intraperitoneal injections of αPDL1 (200 μg/injection on days 4, 8, 14, and 18; clone 10F.9G2; BioXcell), and HMGN1 and its-derived peptdies (0.08 μg on days 9 ...
-
bioRxiv - Cancer Biology 2023Quote: ... or isotype control antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone LTF2, BioXcell).
-
bioRxiv - Bioengineering 2023Quote: ... anti-mouse CTLA-4 (BE0131) and anti-mouse PD-L1 (BE0101) antibodies were purchased from Bioxcell (Lebanon, NH). Anti-human PD-L1 antibody (10084-R639) ...
-
bioRxiv - Immunology 2019Quote: ... The PBMCs were stimulated with 4 μg/mL of plate-bound anti-CD3 antibody (clone OKT3; Bio X cell), 2 μg/mL of soluble anti-CD28 antibody (clone CD28.2 ...
-
bioRxiv - Immunology 2022Quote: ... and then transferred to a 96 well plate that had been coated overnight at 4°C with 5µg/ml αCD3 (BE0001-1, BioXcell), 5µg/ml CD80-Fc (555404 ...
-
bioRxiv - Immunology 2022Quote: ... cells were stained in the dark for 20 minutes at 4°C with fluorochrome- or biotin-conjugated antibodies in PBS containing anti-CD16/CD32 (2.4G2; BioXcell) in the dark ...
-
bioRxiv - Immunology 2022Quote: ... Cells were washed in PBS followed by surface staining for 30 min at 4°C with directly conjugated antibodies diluted in FACS buffer containing anti-CD16/32 (clone 2.4G2; BioXCell) to block non-specific binding ...
-
bioRxiv - Microbiology 2023Quote: ... the cells were incubated with a primary antibody against LCMV NP (VL-4, Bio X Cell, Lebanon, NH, USA), followed by a secondary anti-rat IgG antibody conjugated with Alexa Fluor 568 (anti-rat-AF568 ...
-
bioRxiv - Immunology 2022Quote: For checkpoint blockade therapy 100 μg each of anti-CTLA-4 (Clone UC10-4F10-11, Bio X Cell BP0032) and anti-PD-L1 (Clone 10F.9G2 ...
-
bioRxiv - Cancer Biology 2023Quote: ... injection of either a-PD-L1 antibody (200μg twice weekly for 2 weeks, a total of 4 times; clone 10F.9G2, BioXcell) or isotype control antibody (200μg twice weekly for 2 weeks ...
-
bioRxiv - Biochemistry 2019Quote: ... 1 mM STF-1084 in PBS or PBS alone were injected intratumorally and 200 μg of anti-CTLA-4 antibody or Syrian hamster IgG antibody (both BioXCell) were injected intraperitoneally on day 2 ...
-
bioRxiv - Cancer Biology 2020Quote: ... with 200 μg of ◻PD-L1 (10F.9G2) or αPD-1 (RMP1-14) or αCTLA-4 (9H10) antibody or with isotype control antibodies (all from BioXcell) on days 9 ...
-
bioRxiv - Cancer Biology 2021Quote: Mice were treated with either IgG (5 mg/kg as an anti-4-1BB control, 10 mg/kg as an anti-PD-1 control, BioXcell), anti-4-1BB agonist (5 mg/kg ...
-
bioRxiv - Microbiology 2021Quote: ... 10 μg·ml-1 anti-IL-4 and 10 μg·ml-1 anti-IL-2 (Bio X Cell, Cat# BE0043-1, RRID:AB_1107705). For Treg cell differentiation ...
-
bioRxiv - Cancer Biology 2022Quote: ... Cells were washed with PBS followed by surface staining at 4 °C with directly conjugated antibodies (see list below) diluted in FACS buffer containing anti-CD16/32 (BioXCell, BE0307 ...
-
bioRxiv - Immunology 2023Quote: ... Th1 cells were generated by addition of IL-12 at a concentration of 10 ng/ml and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml into the culture ...
-
bioRxiv - Immunology 2023Quote: ... Th1 cells were generated by addition of IL-12 at a concentration of 10 ng/ml and anti-IL-4 antibody (clone 11B11, BioXCell) at a concentration of 10 µg/ml into the culture ...
-
bioRxiv - Immunology 2023Quote: ... into Th1 cells – 10 ng mL-1 rmIL-12 (R&D Biosystems) plus anti-IL-4 (10 μg mL-1, BioXcell), or Th17 – rhTGFβ (3 ng mL-1 ...
-
bioRxiv - Immunology 2023Quote: ... and fixable live/dead dye for 30min at 4°C in the presence of Fc block (2.4G2; Bio X Cell), fixed and permeabilized (Tonbo Biosciences ...
-
bioRxiv - Immunology 2023Quote: ... three times per week) for 4 weeks and treated with 250 µg of mouse anti–IL-17a (clone 17F3, BioXcell) antibody intraperitoneally in a volume of 200 µL (diluted in PBS ...
-
bioRxiv - Immunology 2023Quote: ... tumor-bearing mice were injected intraperitoneally with 100 μg of anti-CTLA-4 (clone UC10-4F10-11, Bio X Cell) and 100 μg of anti-PD-L1 (clone 10F.9G2 ...
-
bioRxiv - Immunology 2023Quote: ... Cells were washed in FACS buffer followed by surface staining for 30 min at 4°C with directly conjugated antibodies diluted in FACS buffer containing 1:100 anti-CD16/32 (Fc block; BioXCell) to block non-specific binding ...
-
bioRxiv - Immunology 2021Quote: ... Cells (4 × 108 per ml) were incubated on ice for 10 min with anti-CD16/32 ‘Fc block’ (2.4G2; Bio X Cell) prior to staining in the dark for 30 min on ice with fluorophore or biotin-labeled monoclonal antibodies prepared in brilliant stain buffer (BD Biosciences ...
-
bioRxiv - Synthetic Biology 2019Quote: Antibodies used for in vivo experiments include: anti-mouse PD-L1 (BioXCell cat: BE0101and anti-mouse CTLA-4 (BioXCell cat: BE0164). Pre-conjugated primary antibodies used for flow cytometry and microscopy include ...
-
bioRxiv - Cancer Biology 2020Quote: ... were used for checkpoint blocking on tumors as well as T cells: functional grade PD-L1 (29E.2A3) and CTLA-4 (BN13) (Bioxcell, USA). In brief ...
-
bioRxiv - Immunology 2023Quote: ... cells were stained in the dark for 15 min at 4°C with fluorochrome-conjugated antibodies in PBS containing anti-CD16/CD32 (2.4G2; BioXcell or BioLegend). Cells were washed and ...
-
bioRxiv - Immunology 2023Quote: ... LCMV-NP (self-conjugated to AF488 using Thermo Fisher AF488 labeling kit per manufacturer’s instructions, BioXcell, 1:50, clone VL-4).
-
bioRxiv - Bioengineering 2023Quote: ... Mice in groups receiving αPD-1 and αCTLA-4 (100 µg, every 3 days for 5 injections, BioXcell, West Lebanon NH) were treated intraperitoneally ...
-
bioRxiv - Immunology 2021Quote: ... 1% GlutaMAX™ and 1% N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid [Gibco® HEPES]) and used as follow: TH1 conditions with anti–IL-4 (10 μg/mL, BioXCell, #BE0045) and IL-12 (10 ng/mL ...
-
bioRxiv - Immunology 2019Quote: ... For Th2 induction 1×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell) and αCD28 (10 μg mL−1 ...
-
bioRxiv - Immunology 2019Quote: ... 2 to 3×105 naïve T cells were cultured for 4 days with plate-bound αCD3ε (10 μg mL−1, clone 145-2C11; Bio X Cell), αCD28 (1 μg/mL ...
-
bioRxiv - Cancer Biology 2023Quote: ... and anti-CTLA-4 (BXC-BE0131) antibodies or isotype controls (BXC-BE0094 and BXC-BP0087) twice per week (10 mg/kg each, Bio X cell). Therapies started at day 70 for all mice ...
-
bioRxiv - Cancer Biology 2023Quote: ... were injected intraperitoneally with monoclonal antibodies against PD-1 (RMP1-14, 250 μg per dose) and CLTA-4 (9D9, 100 μg per dose) (BioXCell, Lebanon, NH) in sterile PBS or a control PBS solution (25) ...
-
bioRxiv - Immunology 2021Quote: ... – and in vivo ICI treatment – anti-mouse PD-1 (RMP1-14) and anti-mouse CTLA-4 (9D9) – were purchased from Bio X Cell (USA). For T cell depletion ...
-
bioRxiv - Cell Biology 2023Quote: ... was induced by microinjection of 0.5 mg/ml affinity purified rabbit anti-GM130 antibodies (morsel) (Wei et al., 2015) or 0.5 mg/ml anti-DDDDK IgG (Bio X Cell) as control mixed with 2 mg/ml Texas-Red dextran (Invitrogen ...
-
bioRxiv - Cancer Biology 2021Quote: Six month old KRC mice were enrolled onto the anti CTLA-4 treatment trial and treated with either anti-CTLA4 antibody (clone 9H10; Bio X Cell, Lebanon, NH) or InVivoPlus Syrian hamster IgG isotype control antibody (Cat# BP0087 ...
-
bioRxiv - Microbiology 2021Quote: ... naïve CD4+ T cells were cultured with 10 ng·ml-1 IL-12 (R&D, Cat# 402-ML-020/CF) and 10 μg·ml-1 anti-IL-4 (Bio X Cell, Cat# BE0045, RRID:AB_1107707). For Th17 cell differentiation ...
-
bioRxiv - Immunology 2021Quote: ... The following antibodies were used for in vivo blocking experiments: anti-LFA-1α (M17/4) and anti-Mac-1 (M1/70) (both from Bio X Cell, West Lebanon, NH). The following antibodies or reagents were used for in vivo cell depletion ...